Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
50.50
+0.19 (0.38%)
Jan 28, 2026, 4:00 PM EST - Market closed

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $396.00K in the quarter ending September 30, 2025, a decrease of -81.77%. This brings the company's revenue in the last twelve months to $3.08M, down -42.64% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.

Revenue (ttm)
$3.08M
Revenue Growth
-42.64%
P/S Ratio
703.46
Revenue / Employee
$39,462
Employees
78
Market Cap
2.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--